PubRank

Richard E Nettles

Author PubWeight™ 31.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 2010 8.95
2 Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol 2006 5.41
3 Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J Infect Dis 2004 3.30
4 Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A 2013 2.79
5 G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol 2005 2.61
6 Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5A replication complex inhibitor, BMS-790052. Hepatology 2012 2.29
7 Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations. Hepatology 2011 2.10
8 HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother 2006 1.63
9 A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. J Virol 2005 1.32
10 Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug. J Pharm Sci 2013 1.00
11 Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia: genetic screening is unnecessary. J Infect Dis 2006 0.79
12 Clinical implications of HIV viral load blips. Hopkins HIV Rep 2005 0.75